Search results

67 results

Sorted by Relevance . Sort by Date

Guidance Remove Guidance filter
In development Remove In development filter
NICE guidelines Remove NICE guidelines filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Public health guidelines Remove Public health guidelines filter

Atopic Dermatitis (Eczema)

In development [GID-NG10289] Expected publication date: TBC

Type

NICE guideline

Status

In development
Maternal and child nutrition

In development [GID-NG10191] Expected publication date: 22 November 2023

Type

NICE guideline

Status

In development
Advocacy services for adults with health and social care needs

In development [GID-NG10156] Expected publication date: 09 November 2022

Type

NICE guideline

Status

In development
Fractures (complex): assessment and management

In development [GID-NG10328] Expected publication date: 07 December 2022

Type

NICE guideline

Status

In development
Delirium: prevention, diagnosis and management

In development [GID-NG10332] Expected publication date: 18 January 2023

Type

NICE guideline

Status

In development
Alcohol-use disorders: prevention (update)

In development [GID-NG10299] Expected publication date: TBC

Type

NICE guideline

Status

In development
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818

In development [GID-HST10040] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

In development [GID-HST10038] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

In development [GID-HST10004] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]

In development [GID-HST10050] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]

In development [GID-HST10037] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

In development [GID-HST10019] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

In development [GID-HST10007] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Skin abscess: antimicrobial prescribing

In development [GID-NG10163] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Conjunctivitis: antimicrobial prescribing

In development [GID-NG10166] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Blepharitis: antimicrobial prescribing

In development [GID-NG10168] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development
Stye: antimicrobial prescribing

In development [GID-NG10167] Expected publication date: TBC

Type

Antimicrobial prescribing guideline

Status

In development

Filter (5 in use)

Area of interest

Type 1 selected

Status 1 selected

Last updated

Guidance programme 3 selected

67 results

Atopic Dermatitis (Eczema)

Maternal and child nutrition

Advocacy services for adults with health and social care needs

Fractures (complex): assessment and management

Delirium: prevention, diagnosis and management

Alcohol-use disorders: prevention (update)

Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818

Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]

Arimoclomol for treating Niemann-Pick disease Type C [ID1312]

Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

Skin abscess: antimicrobial prescribing

Conjunctivitis: antimicrobial prescribing

Blepharitis: antimicrobial prescribing

Stye: antimicrobial prescribing